Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
$772K Buy
9,613
+3,474
+57% +$278K 0.12% 72
2019
Q2
$491K Sell
6,139
-6,162
-50% -$472K 0.09% 75
2019
Q1
$976K Sell
12,301
-602
-5% -$45K 0.16% 67
2018
Q4
$941K Buy
12,903
+6,380
+98% +$450K 0.18% 65
2018
Q3
$442K Buy
6,523
+1,064
+19% +$67.8K 0.08% 79
2018
Q2
$316K Sell
5,459
-6,348
-54% -$358K 0.06% 83
2018
Q1
$614K Sell
11,807
-140
-1% -$7.56K 0.11% 78
2017
Q4
$641K Buy
11,947
+6,380
+115% +$354K 0.11% 76
2017
Q3
$340K Sell
5,567
-167
-3% -$10.1K 0.07% 82
2017
Q2
$351K Buy
5,734
+631
+12% +$38.4K 0.07% 81
2017
Q1
$309K Sell
5,103
-81
-2% -$4.91K 0.07% 83
2016
Q4
$291K Buy
5,184
+171
+3% +$10K 0.06% 84
2016
Q3
$299K Buy
5,013
+15
+0.3% +$877 0.06% 84
2016
Q2
$275K Buy
4,998
+190
+4% +$10.1K 0.06% 88
2016
Q1
$243K Sell
4,808
-2,800
-37% -$137K 0.05% 89
2015
Q4
$383K Buy
7,608
+686
+10% +$34.6K 0.09% 83
2015
Q3
$326K Buy
6,922
+2,163
+45% +$115K 0.08% 86
2015
Q2
$259K Buy
4,759
+15
+0.3% +$841 0.06% 91
2015
Q1
$260K Buy
4,744
+13
+0.3% +$736 0.06% 93
2014
Q4
$256K Buy
4,731
+14
+0.3% +$780 0.06% 97
2014
Q3
$267K Buy
4,717
+14
+0.3% +$786 0.06% 96
2014
Q2
$260K Buy
4,703
+13
+0.3% +$709 0.06% 98
2014
Q1
$254K Sell
4,690
-588
-11% -$30.4K 0.06% 97
2013
Q4
$252K Buy
5,278
+17
+0.3% +$777 0.06% 96
2013
Q3
$239K Buy
5,261
+16
+0.3% +$731 0.06% 96
2013
Q2
$232K Buy
+5,245
New +$234K 0.06% 95

Other funds holding MRK

Halsey Associates's MRK Position: Q3 2019 in Review

Halsey Associates increased its Merck (MRK) stake by 57% in Q3 2019, buying an estimated $278K and bringing the position to 9,613 shares worth $772K. The position accounts for 0.12% of the portfolio, ranked #72.

Halsey Associates first reported a position in MRK in Q2 2013 and has held it in 26 quarters since. The position peaked at $976K in Q1 2019. 2,305 funds tracked by Wall St. Rank hold MRK as of Q3 2019.

  • Halsey Associates held 9,613 shares of Merck worth $772K as of Q3 2019.
  • Halsey Associates bought 3,474 Merck shares in Q3 2019, an estimated $278K.
  • Merck made up 0.12% of Halsey Associates's portfolio in Q3 2019, its #72 holding.
  • Halsey Associates first reported a position in Merck in Q2 2013 and has held it in 26 quarters since.
  • Halsey Associates's Merck position peaked at $976K in Q1 2019.
  • 2,305 funds tracked by Wall St. Rank held Merck as of Q3 2019.

Based on Halsey Associates's 13F filing for Q3 2019, filed 15 Nov 2019.